{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T05:39:50Z","timestamp":1790228390679,"version":"4.1.0"},"reference-count":145,"publisher":"Bentham Science Publishers Ltd.","issue":"23","funder":[{"DOI":"10.13039\/501100001843","name":"Science and Engineering Research Board (SERB), New Delhi","doi-asserted-by":"publisher","award":["ECR\/2015\/000541"],"award-info":[{"award-number":["ECR\/2015\/000541"]}],"id":[{"id":"10.13039\/501100001843","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CMC"],"published-print":{"date-parts":[[2020,7,1]]},"abstract":"<jats:sec><jats:title\/><jats:p>Zika Virus (ZIKV) belongs to the class of flavivirus that can be transmitted by Aedes mosquitoes. The number of Zika virus caused cases of acute infections, neurological disorders and congenital microcephaly are rapidly growing and therefore, in 2016, the World Health Organization declared a global \u201cPublic Health Emergency of International Concern\u201d. Anti-ZIKV therapeutic and vaccine development strategies are growing worldwide in recent years, however, no specific and safe treatment is available till date to save the human life. Currently, development of peptide therapeutics against ZIKV has attracted rising attention on account of their high safety concern and low development cost, in comparison to small therapeutic molecules and antibody-based anti-viral drugs. In present review, an overview of ZIKV inhibition by peptide-based inhibitors including E-protein derived peptides, antimicrobial peptides, frog skin peptides and probiotic peptides has been discussed. Peptides inhibitors have also been reported to act against NS5, NS2B-NS3 protease and proteasome in order to inhibit ZIKV infection. Recent advances in peptide-based therapeutics and vaccine have been reviewed and their future promise against ZIKV infections has been explored.<\/jats:p><\/jats:sec>","DOI":"10.2174\/0929867326666190111115132","type":"journal-article","created":{"date-parts":[[2019,1,14]],"date-time":"2019-01-14T04:52:52Z","timestamp":1547441572000},"page":"3906-3923","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Therapeutic Applications of Peptides against Zika Virus: A Review"],"prefix":"10.2174","volume":"27","author":[{"given":"Preeti","family":"Karwal","sequence":"first","affiliation":[{"name":"Department of Biochemistry, Deshbandhu College, University of Delhi, Delhi-110019, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ishwar Dutt","family":"Vats","sequence":"additional","affiliation":[{"name":"Department of Chemistry, Deshbandhu College, University of Delhi, Delhi-110019, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niharika","family":"Sinha","sequence":"additional","affiliation":[{"name":"Drug Development Laboratory Group, Gautam Buddha University, Noida, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anchal","family":"Singhal","sequence":"additional","affiliation":[{"name":"Department of Chemistry, St. Joseph's College, Bengaluru, Karnataka, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teena","family":"Sehgal","sequence":"additional","affiliation":[{"name":"Department of Chemistry, HMRITM, GGSIP University, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pratibha","family":"Kumari","sequence":"additional","affiliation":[{"name":"Department of Chemistry, Deshbandhu College, University of Delhi, Delhi-110019, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"1981","DOI":"10.1056\/NEJMsr1604338","volume":"374","author":"Rasmussen S.A.","year":"2016","unstructured":"Rasmussen S.A.; Jamieson D.J.; Honein M.A.; Petersen L.R.; Zika virus and birth defects-reviewing the evidence for causality. N Engl J Med 2016,374(20),1981-1987","journal-title":"N Engl J Med"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"925","DOI":"10.3201\/eid2205.151934","volume":"22","author":"Arzuza-Ortega L.","year":"2016","unstructured":"Arzuza-Ortega L.; Polo A.; P\u00e9rez-Tatis G.; L\u00f3pez-Garc\u00eda H.; Parra E.; Pardo-Herrera L.C.; Rico-Turca A.M.; Villamil-G\u00f3mez W.; Rodr\u00edguez-Morales A.J.; Fatal sickle cell disease and zika virus infection in girl from Colombia. Emerg Infect Dis 2016,22(5),925-927","journal-title":"Emerg Infect Dis"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"4780","DOI":"10.1128\/JVI.02586-15","volume":"90","author":"Ashraf U.","year":"2016","unstructured":"Ashraf U.; Zhu B.; Ye J.; Wan S.; Nie Y.; Chen Z.; Cui M.; Wang C.; Duan X.; Zhang H.; Chen H.; Cao S.; MicroRNA-19b-3p modulates Japanese encephalitis virus-mediated inflammation via targeting RNF11. J Virol 2016,90(9),4780-4795","journal-title":"J Virol"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"i657","DOI":"10.1136\/bmj.i657","volume":"352","author":"Gulland A.","year":"2016","unstructured":"Gulland A.; Zika virus is a global public health emergency, declares WHO. BMJ 2016,352,i657","journal-title":"BMJ"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.3201\/eid1408.080287","volume":"14","author":"Lanciotti R.S.","year":"2008","unstructured":"Lanciotti R.S.; Kosoy O.L.; Laven J.J.; Velez J.O.; Lambert A.J.; Johnson A.J.; Stanfield S.M.; Duffy M.R.; Genetic and serologic properties of Zika virus associated with an epidemic, Yap State, Micronesia, 2007. Emerg Infect Dis 2008,14(8),1232-1239","journal-title":"Emerg Infect Dis"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"2199","DOI":"10.2174\/1568026617666170130122921","volume":"17","author":"Gautam R.","year":"2017","unstructured":"Gautam R.; Mishra S.; Milhotra A.; Nagpal R.; Mohan M.; Singhal A.; Kumari P.; Challenges with mosquito-borne viral diseases: outbreak of the monsters. Curr Top Med Chem 2017,17(19),2199-2214","journal-title":"Curr Top Med Chem"},{"key":"ref=7","first-page":"1101","author":"Lindenbach B.D.","year":"2007","unstructured":"Lindenbach B.D.; Thiel H.J.; Rice C.M.; Flaviviridae: the viruses and their replication 2007,1101-1133","journal-title":"Flaviviridae: the viruses and their replication"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.micinf.2011.01.002","volume":"13","author":"Unni S.K.","year":"2011","unstructured":"Unni S.K.; R\u016f\u017eek D.; Chhatbar C.; Mishra R.; Johri M.K.; Singh S.K.; Japanese encephalitis virus: from genome to infectome. Microbes Infect 2011,13(4),312-321","journal-title":"Microbes Infect"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.3201\/eid1509.090442","volume":"15","author":"Hayes E.B.","year":"2009","unstructured":"Hayes E.B.; Zika virus outside Africa. Emerg Infect Dis 2009,15(9),1347-1350","journal-title":"Emerg Infect Dis"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.vetmic.2009.08.025","volume":"140","author":"Weissenb\u00f6ck H.","year":"2010","unstructured":"Weissenb\u00f6ck H.; Hub\u00e1lek Z.; Bakonyi T.; Nowotny N.; Zoonotic mosquito-borne flaviviruses: worldwide presence of agents with proven pathogenicity and potential candidates of future emerging diseases. Vet Microbiol 2010,140(3-4),271-280","journal-title":"Vet Microbiol"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/0035-9203(52)90042-4","volume":"46","author":"Dick G.W.","year":"1952","unstructured":"Dick G.W.; Kitchen S.F.; Haddow A.J.; Zika virus. I. Isolations and serological specificity. Trans R Soc Trop Med Hyg 1952,46(5),509-520","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1080\/00034983.1975.11686983","volume":"69","author":"Moore D.L.","year":"1975","unstructured":"Moore D.L.; Causey O.R.; Carey D.E.; Reddy S.; Cooke A.R.; Akinkugbe F.M.; David-West T.S.; Kemp G.E.; Arthropod-borne viral infections of man in Nigeria, 1964-1970. Ann Trop Med Parasitol 1975,69(1),49-64","journal-title":"Ann Trop Med Parasitol"},{"key":"ref=13","doi-asserted-by":"crossref","first-page":"223","DOI":"10.4049\/jimmunol.69.2.223","volume":"69","author":"Smithburn K.C.","year":"1952","unstructured":"Smithburn K.C.; Neutralizing antibodies against certain recently isolated viruses in the sera of human beings residing in East Africa. J Immunol 1952,69(2),223-234","journal-title":"J Immunol"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/0035-9203(54)90006-1","volume":"48","author":"MacNamara F.N.","year":"1954","unstructured":"MacNamara F.N.; Zika virus: a report on three cases of human infection during an epidemic of jaundice in Nigeria. Trans R Soc Trop Med Hyg 1954,48(2),139-145","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/0035-9203(81)90100-0","volume":"75","author":"Olson J.G.","year":"1981","unstructured":"Olson J.G.; Ksiazek T.G.; Suhandiman ; Triwibowo ; Zika virus, a cause of fever in Central Java, Indonesia. Trans R Soc Trop Med Hyg 1981,75(3),389-393","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"2536","DOI":"10.1056\/NEJMoa0805715","volume":"360","author":"Duffy M.R.","year":"2009","unstructured":"Duffy M.R.; Chen T.H.; Hancock W.T.; Powers A.M.; Kool J.L.; Lanciotti R.S.; Pretrick M.; Marfel M.; Holzbauer S.; Dubray C.; Guillaumot L.; Griggs A.; Bel M.; Lambert A.J.; Laven J.; Kosoy O.; Panella A.; Biggerstaff B.J.; Fischer M.; Hayes E.B.; Zika virus outbreak on Yap Island, Federated States of Micronesia. N Engl J Med 2009,360(24),2536-2543","journal-title":"N Engl J Med"},{"key":"ref=17","year":"2014","unstructured":"European Centre for Disease Prevention and Control Rapid risk assessment: Zika virus infection outbreak, French Polynesia Available at:2014","journal-title":"Rapid risk assessment: Zika virus infection outbreak, French Polynesia"},{"key":"ref=18","year":"2016","unstructured":"European Centre for Disease Prevention and Control Rapid risk assessment: Zika virus disease epidemic: potential association with microcephaly and Guillain-Barr\u00e9 syndrome - 6th update Available at:2016","journal-title":"Rapid risk assessment: Zika virus disease epidemic: potential association with microcephaly and Guillain-Barr\u00e9 syndrome - 6th update"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"20929","DOI":"10.2807\/1560-7917.es2014.19.41.20929","volume":"19","author":"Roth A.","year":"2014","unstructured":"Roth A.; Mercier A.; Lepers C.; Hoy D.; Duituturaga S.; Benyon E.; Guillaumot L.; Souares Y.; Concurrent outbreaks of dengue, chikungunya and Zika virus infections - an unprecedented epidemic wave of mosquito-borne viruses in the Pacific 2012-2014. Euro Surveill 2014,19(41),20929","journal-title":"Euro Surveill"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1016\/S0140-6736(16)00624-3","volume":"387","author":"Dupont-Rouzeyrol M.","year":"2016","unstructured":"Dupont-Rouzeyrol M.; Biron A.; O\u2019Connor O.; Huguon E.; Descloux E.; Infectious Zika viral particles in breastmilk. Lancet 2016,387(10023),1051","journal-title":"Lancet"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"1885","DOI":"10.3201\/eid2110.150847","volume":"21","author":"Campos G.S.","year":"2015","unstructured":"Campos G.S.; Bandeira A.C.; Sardi S.I.; Zika virus outbreak, Bahia, Brazil. Emerg Infect Dis 2015,21(10),1885-1886","journal-title":"Emerg Infect Dis"},{"key":"ref=22","first-page":"609","volume":"45","year":"2015","unstructured":"World Health Organization. Zika virus outbreaks in the Americas. Weekly Epidemiological Record: Relev\u00e9 \u00e9pid\u00e9miologique hebdomadaire Available at:2015,45(90),609-616","journal-title":"Weekly Epidemiological Record: Relev\u00e9 \u00e9pid\u00e9miologique hebdomadaire"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1099\/jgv.0.000381","volume":"97","author":"Gatherer D.","year":"2016","unstructured":"Gatherer D.; Kohl A.; Zika virus: a previously slow pandemic spreads rapidly through the Americas. J Gen Virol 2016,97(2),269-273","journal-title":"J Gen Virol"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"55","DOI":"10.15585\/mmwr.mm6503e1","volume":"65","author":"Hennessey M.","year":"2016","unstructured":"Hennessey M.; Fischer M.; Staples J.E.; Zika virus spreads to new areas- region of the Americas, May 2015-January 2016. MMWR Morb Mortal Wkly Rep 2016,65(3),55-58","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1056\/NEJMp1600297","volume":"374","author":"Fauci A.S.","year":"2016","unstructured":"Fauci A.S.; Morens D.M.; Zika virus in the Americas yet another arbovirus threat. N Engl J Med 2016,374(7),601-604","journal-title":"N Engl J Med"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"613","DOI":"10.7326\/M16-0150","volume":"164","author":"Chen L.H.","year":"2016","unstructured":"Chen L.H.; Hamer D.H.; Zika virus: rapid spread in the Western Hemisphere. Ann Intern Med 2016,164(9),613-615","journal-title":"Ann Intern Med"},{"key":"ref=27","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0004687","volume":"10","author":"Lednicky J.","year":"2016","unstructured":"Lednicky J.; Beau De Rochars V.M.; El Badry M.; Loeb J.; Telisma T.; Chavannes S.; Anilis G.; Cella E.; Ciccozzi M.; Rashid M.; Okech B.; Salemi M.; Morris J.G.; Zika virus outbreak in Haiti in 2014: molecular and clinical data. PLoS Negl Trop Dis 2016,10(4)","journal-title":"PLoS Negl Trop Dis"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"123","DOI":"10.4103\/1947-2714.179112","volume":"8","author":"Hajra A.","year":"2016","unstructured":"Hajra A.; Bandyopadhyay D.; Hajra S.K.; Zika virus: a global threat to humanity: a comprehensive review and current developments. N Am J Med Sci 2016,8(3),123-128","journal-title":"N Am J Med Sci"},{"key":"ref=29","year":"2012","unstructured":"Centers for Disease Control and Prevention CDC adds countries to interim travel guidance related to Zika virus, Available at:2012","journal-title":"CDC adds countries to interim travel guidance related to Zika virus,"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"675","DOI":"10.2471\/BLT.16.171082","volume":"94","author":"Kindhauser M.K.","year":"2016","unstructured":"Kindhauser M.K.; Allen T.; Frank V.; Santhana R.S.; Dye C.; Zika: the origin and spread of a mosquito-borne virus. Bull World Health Organ 2016,94(9),675-686C","journal-title":"Bull World Health Organ"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"9073","DOI":"10.1073\/pnas.0403164101","volume":"101","author":"Zhu J.","year":"2004","unstructured":"Zhu J.; Trang P.; Kim K.; Zhou T.; Deng H.; Liu F.; Effective inhibition of Rta expression and lytic replication of Kaposi\u2019s sarcoma-associated herpesvirus by human RNase P. Proc Natl Acad Sci USA 2004,101(24),9073-9078","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/S0076-6879(05)91020-3","volume":"391","author":"D\u00fczg\u00fcne\u015f N.","year":"2005","unstructured":"D\u00fczg\u00fcne\u015f N.; Sim\u00f5es S.; Slepushkin V.; Pretzer E.; Flasher D.; Salem I.I.; Steffan G.; Konopka K.; Pedroso de Lima M.C.; Delivery of antiviral agents in liposomes. Methods Enzymol 2005,391,351-373","journal-title":"Methods Enzymol"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.antiviral.2009.08.003","volume":"84","author":"Clayton R.","year":"2009","unstructured":"Clayton R.; Ohagen A.; Nicol F.; Del Vecchio A.M.; Jonckers T.H.M.; Goethals O.; Van Loock M.; Michiels L.; Grigsby J.; Xu Z.; Zhang Y.P.; Gutshall L.L.; Cunningham M.; Jiang H.; Bola S.; Sarisky R.T.; Hertogs K.; Sustained and specific in vitro inhibition of HIV-1 replication by a protease inhibitor encapsulated in gp120-targeted liposomes. Antiviral Res 2009,84(2),142-149","journal-title":"Antiviral Res"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1016\/j.ymthe.2003.12.013","volume":"9","author":"Pan W.H.","year":"2004","unstructured":"Pan W.H.; Xin P.; Morrey J.D.; Clawson G.A.; A self-processing ribozyme cassette: utility against human papillomavirus 11 E6\/E7 mRNA and hepatitis B virus. Mol Ther 2004,9(4),596-606","journal-title":"Mol Ther"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"16010","DOI":"10.1074\/jbc.272.25.16010","volume":"272","author":"Viv\u00e8s E.","year":"1997","unstructured":"Viv\u00e8s E.; Brodin P.; Lebleu B.; A truncated HIV-1 Tat protein basic domain rapidly translocates through the plasma membrane and accumulates in the cell nucleus. J Biol Chem 1997,272(25),16010-16017","journal-title":"J Biol Chem"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1016\/0092-8674(88)90263-2","volume":"55","author":"Frankel A.D.","year":"1988","unstructured":"Frankel A.D.; Pabo C.O.; Cellular uptake of the tat protein from human immunodeficiency virus. Cell 1988,55(6),1189-1193","journal-title":"Cell"},{"key":"ref=37","doi-asserted-by":"crossref","first-page":"10444","DOI":"10.1016\/S0021-9258(17)34080-2","volume":"269","author":"Derossi D.","year":"1994","unstructured":"Derossi D.; Joliot A.H.; Chassaing G.; Prochiantz A.; The third helix of the Antennapedia homeodomain translocates through biological membranes. J Biol Chem 1994,269(14),10444-10450","journal-title":"J Biol Chem"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"2099","DOI":"10.1016\/S0140-6736(17)31450-2","volume":"390","author":"Baud D.","year":"2017","unstructured":"Baud D.; Gubler D.J.; Schaub B.; Lanteri M.C.; Musso D.; An update on Zika virus infection. Lancet 2017,390(10107),2099-2109","journal-title":"Lancet"},{"key":"ref=39","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2019.104637","volume":"172","author":"Loe M.W.C.","year":"2019","unstructured":"Loe M.W.C.; Lee R.C.H.; Chu J.J.H.; Antiviral activity of the FDA-approved drug candesartan cilexetil against Zika virus infection. Antiviral Res 2019,172","journal-title":"Antiviral Res"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"2323","DOI":"10.1016\/j.celrep.2016.05.074","volume":"15","author":"Savidis G.","year":"2016","unstructured":"Savidis G.; Perreira J.M.; Portmann J.M.; Meraner P.; Guo Z.; Green S.; Brass A.L.; The IFITMs inhibit zika virus replication. Cell Rep 2016,15(11),2323-2330","journal-title":"Cell Rep"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1038\/nm.4184","volume":"22","author":"Xu M.","year":"2016","unstructured":"Xu M.; Lee E.M.; Wen Z.; Cheng Y.; Huang W.K.; Qian X.; Tcw J.; Kouznetsova J.; Ogden S.C.; Hammack C.; Jacob F.; Nguyen H.N.; Itkin M.; Hanna C.; Shinn P.; Allen C.; Michael S.G.; Simeonov A.; Huang W.; Christian K.M.; Goate A.; Brennand K.J.; Huang R.; Xia M.; Ming G.L.; Zheng W.; Song H.; Tang H.; Identification of small-molecule inhibitors of Zika virus infection and induced neural cell death via a drug repurposing screen. Nat Med 2016,22(10),1101-1107","journal-title":"Nat Med"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.antiviral.2016.11.023","volume":"137","author":"Bullard-Feibelman K.M.","year":"2017","unstructured":"Bullard-Feibelman K.M.; Govero J.; Zhu Z.; Salazar V.; Veselinovic M.; Diamond M.S.; Geiss B.J.; The FDA-approved drug sofosbuvir inhibits Zika virus infection. Antiviral Res 2017,137,134-140","journal-title":"Antiviral Res"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"1552","DOI":"10.1056\/NEJMra1602113","volume":"374","author":"Petersen L.R.","year":"2016","unstructured":"Petersen L.R.; Jamieson D.J.; Powers A.M.; Honein M.A.; Zika Virus. N Engl J Med 2016,374(16),1552-1563","journal-title":"N Engl J Med"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"359","DOI":"10.3201\/eid2102.141363","volume":"21","author":"Musso D.","year":"2015","unstructured":"Musso D.; Roche C.; Robin E.; Nhan T.; Teissier A.; Cao-Lormeau V.M.; Potential sexual transmission of Zika virus. Emerg Infect Dis 2015,21(2),359-361","journal-title":"Emerg Infect Dis"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"120","DOI":"10.15585\/mmwr.mm6505e1","volume":"65","author":"Oster A.M.","year":"2016","unstructured":"Oster A.M.; Brooks J.T.; Stryker J.E.; Kachur R.E.; Mead P.; Pesik N.T.; Petersen L.R.; Interim guidelines for prevention of sexual transmission of zika virus- United States, 2016. MMWR Morb Mortal Wkly Rep 2016,65(5),120-121","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"20761","DOI":"10.2807\/1560-7917.ES2014.19.14.20761","volume":"19","author":"Musso D.","year":"2014","unstructured":"Musso D.; Nhan T.; Robin E.; Roche C.; Bierlaire D.; Zisou K.; Shan Yan A.; Cao-Lormeau V.M.; Broult J.; Potential for Zika virus transmission through blood transfusion demonstrated during an outbreak in French Polynesia, November 2013 to February 2014. Euro Surveill 2014,19(14),20761","journal-title":"Euro Surveill"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.ijid.2015.10.005","volume":"41","author":"Aubry M.","year":"2015","unstructured":"Aubry M.; Finke J.; Teissier A.; Roche C.; Broult J.; Paulous S.; Despr\u00e8s P.; Cao-Lormeau V.M.; Musso D.; Seroprevalence of arboviruses among blood donors in French Polynesia, 2011-2013. Int J Infect Dis 2015,41,11-12","journal-title":"Int J Infect Dis"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1128\/CMR.00072-15","volume":"29","author":"Musso D.","year":"2016","unstructured":"Musso D.; Gubler D.J.; Zika Virus. Clin Microbiol Rev 2016,29(3),487-524","journal-title":"Clin Microbiol Rev"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"1981","DOI":"10.1056\/NEJMsr1604338","volume":"374","author":"Rasmussen S.A.","year":"2016","unstructured":"Rasmussen S.A.; Jamieson D.J.; Honein M.A.; Petersen L.R.; Zika virus and birth defects-reviewing the evidence for causality. N Engl J Med 2016,374(20),1981-1987","journal-title":"N Engl J Med"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"315","DOI":"10.15585\/mmwr.mm6512e2","volume":"65","author":"Petersen E.E.","year":"2016","unstructured":"Petersen E.E.; Polen K.N.D.; Meaney-Delman D.; Ellington S.R.; Oduyebo T.; Cohn A.; Oster A.M.; Russell K.; Kawwass J.F.; Karwowski M.P.; Powers A.M.; Bertolli J.; Brooks J.T.; Kissin D.; Villanueva J.; Mu\u00f1oz-Jordan J.; Kuehnert M.; Olson C.K.; Honein M.A.; Rivera M.; Jamieson D.J.; Rasmussen S.A.; Update: Interim guidance for health care providers caring for women of reproductive age with possible zika virus exposure-united states, 2016. MMWR Morb Mortal Wkly Rep 2016,65(12),315-322","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1056\/NEJMp1605367","volume":"375","author":"Johansson M.A.","year":"2016","unstructured":"Johansson M.A.; Mier-y-Teran-Romero L.; Reefhuis J.; Gilboa S.M.; Hills S.L.; Zika and the risk of microcephaly. N Engl J Med 2016,375(1),1-4","journal-title":"N Engl J Med"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.jcv.2016.09.012","volume":"84","author":"Abushouk A.I.","year":"2016","unstructured":"Abushouk A.I.; Negida A.; Ahmed H.; An updated review of Zika virus. J Clin Virol 2016,84,53-58","journal-title":"J Clin Virol"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1016\/j.apjtb.2016.09.007","volume":"6","author":"Moghadam S.R.J.","year":"2016","unstructured":"Moghadam S.R.J.; Bayrami S.; Moghadam S.J.; Golrokhi R.; Pahlaviani F.G.; SayedAlinaghi, S. Zika virus: a review of literature. Asian Pac J Trop Biomed 2016,6,989-994","journal-title":"Asian Pac J Trop Biomed"},{"key":"ref=54","year":"2016","unstructured":"CENTERS FOR DISEASE CONTROL AND PREVENTION Zika Virus Available at:2016","journal-title":"Zika Virus"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1126\/science.aam7120","volume":"358","author":"Yuan L.","year":"2017","unstructured":"Yuan L.; Huang X.Y.; Liu Z.Y.; Zhang F.; Zhu X.L.; Yu J.Y.; Ji X.; Xu Y.P.; Li G.; Li C.; Wang H.J.; Deng Y.Q.; Wu M.; Cheng M.L.; Ye Q.; Xie D.Y.; Li X.F.; Wang X.; Shi W.; Hu B.; Shi P.Y.; Xu Z.; Qin C.F.; A single mutation in the prM protein of Zika virus contributes to fetal microcephaly. Science 2017,358(6365),933-936","journal-title":"Science"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1097\/INF.0000000000001486","volume":"36","author":"Cunha A.J.","year":"2017","unstructured":"Cunha A.J.; de Magalh\u00e3es-Barbosa M.C.; Lima-Setta F.; Medronho R.A.; Prata-Barbosa A.; Microcephaly case fatality rate associated with zika virus infection in Brazil: current estimates. Pediatr Infect Dis J 2017,36(5),528-530","journal-title":"Pediatr Infect Dis J"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.drudis.2014.10.003","volume":"20","author":"Fosgerau K.","year":"2015","unstructured":"Fosgerau K.; Hoffmann T.; Peptide therapeutics: current status and future directions. Drug Discov Today 2015,20(1),122-128","journal-title":"Drug Discov Today"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1016\/j.soard.2014.01.032","volume":"10","author":"Buchwald H.","year":"2014","unstructured":"Buchwald H.; Dorman R.B.; Rasmus N.F.; Michalek V.N.; Landvik N.M.; Ikramuddin S.; Effects on GLP-1, PYY, and leptin by direct stimulation of terminal ileum and cecum in humans: implications for ileal transposition. Surg Obes Relat Dis 2014,10(5),780-786","journal-title":"Surg Obes Relat Dis"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/j.tube.2014.03.011","volume":"94","author":"Padhi A.","year":"2014","unstructured":"Padhi A.; Sengupta M.; Sengupta S.; Roehm K.H.; Sonawane A.; Antimicrobial peptides and proteins in mycobacterial therapy: current status and future prospects. Tuberculosis (Edinb) 2014,94(4),363-373","journal-title":"Tuberculosis (Edinb)"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"63","DOI":"10.3389\/fneur.2014.00063","volume":"5","author":"Giordano C.","year":"2014","unstructured":"Giordano C.; Marchi\u00f2 M.; Timofeeva E.; Biagini G.; Neuroactive peptides as putative mediators of antiepileptic ketogenic diets. Front Neurol 2014,5,63","journal-title":"Front Neurol"},{"key":"ref=61","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0087648","volume":"9","author":"Robinson S.D.","year":"2014","unstructured":"Robinson S.D.; Safavi-Hemami H.; McIntosh L.D.; Purcell A.W.; Norton R.S.; Papenfuss A.T.; Diversity of conotoxin gene superfamilies in the venomous snail, Conus victoriae. PLoS One 2014,9(2)","journal-title":"PLoS One"},{"key":"ref=62","first-page":"506","volume":"158","author":"Puttagunta A.L.","year":"1998","unstructured":"Puttagunta A.L.; Toth E.L.; Insulin lispro (Humalog), the first marketed insulin analogue: indications, contraindications and need for further study. CMAJ 1998,158(4),506-511","journal-title":"CMAJ"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"526","DOI":"10.3389\/fphar.2016.00526","volume":"7","author":"Recio C.","year":"2017","unstructured":"Recio C.; Maione F.; Iqbal A.J.; Mascolo N.; De Feo V.; The potential therapeutic application of peptides and peptidomimetics in cardiovascular disease. Front Pharmacol 2017,7,526","journal-title":"Front Pharmacol"},{"key":"ref=64","first-page":"54","volume":"42","author":"Lax R.","year":"2012","unstructured":"Lax R.; Meenan C.; Challenges for therapeutic peptides part1: on the inside, looking out. Innov PharmTechnol 2012,42(42),54-56","journal-title":"Innov PharmTechnol"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.euprot.2014.05.003","volume":"4","author":"Uhlig T.","year":"2014","unstructured":"Uhlig T.; Kyprianou T.; Martinelli F.G.; Oppici C.A.; Heiligers D.; Hills D.; Calvo X.R.; Verhaert P.; The emergence of peptides in the pharmaceutical business: from exploration to exploitation. EuPA Open Proteom 2014,4,58-69","journal-title":"EuPA Open Proteom"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"29","DOI":"10.2174\/1389201043489620","volume":"5","author":"Bruckdorfer T.","year":"2004","unstructured":"Bruckdorfer T.; Marder O.; Albericio F.; From production of peptides in milligram amounts for research to multi-tons quantities for drugs of the future. Curr Pharm Biotechnol 2004,5(1),29-43","journal-title":"Curr Pharm Biotechnol"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"361","DOI":"10.4155\/fmc.09.23","volume":"1","author":"Zompra A.A.","year":"2009","unstructured":"Zompra A.A.; Galanis A.S.; Werbitzky O.; Albericio F.; Manufacturing peptides as active pharmaceutical ingredients. Future Med Chem 2009,1(2),361-377","journal-title":"Future Med Chem"},{"key":"ref=68","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0124706","volume":"10","author":"Tripathi S.","year":"2015","unstructured":"Tripathi S.; Wang G.; White M.; Qi L.; Taubenberger J.; Hartshorn K.L.; Antiviral activity of the human cathelicidin, LL37, and derived peptides on seasonal and pandemic influenza A viruses. PLoS One 2015,10(4)","journal-title":"PLoS One"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1159\/000354465","volume":"32","author":"Hou M.","year":"2013","unstructured":"Hou M.; Zhang N.; Yang J.; Meng X.; Yang R.; Li J.; Sun T.; Antimicrobial peptide LL-37 and IDR-1 ameliorate MRSA pneumonia in vivo. Cell Physiol Biochem 2013,32(3),614-623","journal-title":"Cell Physiol Biochem"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1002\/jmv.2134","volume":"66","author":"Belaid A.","year":"2002","unstructured":"Belaid A.; Aouni M.; Khelifa R.; Trabelsi A.; Jemmali M.; Hani K.; In vitro antiviral activity of dermaseptins against herpes simplex virus type 1. J Med Virol 2002,66(2),229-234","journal-title":"J Med Virol"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"755","DOI":"10.2217\/imt.14.37","volume":"6","author":"Gokhale A.S.","year":"2014","unstructured":"Gokhale A.S.; Satyanarayanajois S.; Peptides and peptidomimetics as immunomodulators. Immunotherapy 2014,6(6),755-774","journal-title":"Immunotherapy"},{"key":"ref=72","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0170462","volume":"12","author":"Sun G.","year":"2017","unstructured":"Sun G.; Larsen C.N.; Baumgarth N.; Klem E.B.; Scheuermann R.H.; Comprehensive annotation of mature peptides and genotypes for zika virus. PLoS One 2017,12(1)","journal-title":"PLoS One"},{"key":"ref=73","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1016\/S0092-8674(02)00660-8","volume":"108","author":"Kuhn R.J.","year":"2002","unstructured":"Kuhn R.J.; Zhang W.; Rossmann M.G.; Pletnev S.V.; Corver J.; Lenches E.; Jones C.T.; Mukhopadhyay S.; Chipman P.R.; Strauss E.G.; Baker T.S.; Strauss J.H.; Structure of dengue virus: implications for flavivirus organization, maturation, and fusion. Cell 2002,108(5),717-725","journal-title":"Cell"},{"key":"ref=74","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1038\/nature02165","volume":"427","author":"Modis Y.","year":"2004","unstructured":"Modis Y.; Ogata S.; Clements D.; Harrison S.C.; Structure of the dengue virus envelope protein after membrane fusion. Nature 2004,427(6972),313-319","journal-title":"Nature"},{"key":"ref=75","doi-asserted-by":"publisher","first-page":"2287","DOI":"10.1128\/JVI.02957-12","volume":"87","author":"Klein D.E.","year":"2013","unstructured":"Klein D.E.; Choi J.L.; Harrison S.C.; Structure of a dengue virus envelope protein late-stage fusion intermediate. J Virol 2013,87(4),2287-2293","journal-title":"J Virol"},{"key":"ref=76","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1000851","volume":"6","author":"Schmidt A.G.","year":"2010","unstructured":"Schmidt A.G.; Yang P.L.; Harrison S.C.; Peptide inhibitors of dengue-virus entry target a late-stage fusion intermediate. PLoS Pathog 2010,6(4)","journal-title":"PLoS Pathog"},{"key":"ref=77","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0050995","volume":"7","author":"Lok S.M.","year":"2012","unstructured":"Lok S.M.; Costin J.M.; Hrobowski Y.M.; Hoffmann A.R.; Rowe D.K.; Kukkaro P.; Holdaway H.; Chipman P.; Fontaine K.A.; Holbrook M.R.; Garry R.F.; Kostyuchenko V.; Wimley W.C.; Isern S.; Rossmann M.G.; Michael S.F.; Release of dengue virus genome induced by a peptide inhibitor. PLoS One 2012,7(11)","journal-title":"PLoS One"},{"key":"ref=78","doi-asserted-by":"publisher","first-page":"12549","DOI":"10.1128\/JVI.01440-10","volume":"84","author":"Schmidt A.G.","year":"2010","unstructured":"Schmidt A.G.; Yang P.L.; Harrison S.C.; Peptide inhibitors of flavivirus entry derived from the E protein stem. J Virol 2010,84(24),12549-12554","journal-title":"J Virol"},{"key":"ref=79","doi-asserted-by":"publisher","first-page":"13410","DOI":"10.1038\/ncomms13410","volume":"7","author":"Phoo W.W.","year":"2016","unstructured":"Phoo W.W.; Li Y.; Zhang Z.; Lee M.Y.; Loh Y.R.; Tan Y.B.; Ng E.Y.; Lescar J.; Kang C.; Luo D.; Structure of the NS2B-NS3 protease from Zika virus after self-cleavage. Nat Commun 2016,7,13410","journal-title":"Nat Commun"},{"key":"ref=80","doi-asserted-by":"publisher","first-page":"2725","DOI":"10.3389\/fmicb.2019.02725","volume":"10","author":"Wang L.","year":"2019","unstructured":"Wang L.; Liang R.; Gao Y.; Li Y.; Deng X.; Xiang R.; Zhang Y.; Ying T.; Jiang S.; Yu F.; Development of small-molecule inhibitors against zika virus infection. Front Microbiol 2019,10,2725","journal-title":"Front Microbiol"},{"key":"ref=81","doi-asserted-by":"publisher","first-page":"2840","DOI":"10.1021\/bi2018267","volume":"51","author":"Choksupmanee O.","year":"2012","unstructured":"Choksupmanee O.; Hodge K.; Katzenmeier G.; Chimnaronk S.; Structural platform for the autolytic activity of an intact NS2B-NS3 protease complex from dengue virus. Biochemistry 2012,51(13),2840-2851","journal-title":"Biochemistry"},{"key":"ref=82","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1016\/j.tim.2017.07.001","volume":"25","author":"Kang C.","year":"2017","unstructured":"Kang C.; Keller T.H.; Luo D.; Zika virus protease: an antiviral drug target. Trends Microbiol 2017,25(10),797-808","journal-title":"Trends Microbiol"},{"key":"ref=83","doi-asserted-by":"publisher","first-page":"3422","DOI":"10.2174\/13816128113199990633","volume":"20","author":"Poulsen A.","year":"2014","unstructured":"Poulsen A.; Kang C.; Keller T.H.; Drug design for flavivirus proteases: what are we missing? Curr Pharm Des 2014,20(21),3422-3427","journal-title":"Curr Pharm Des"},{"key":"ref=84","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.chom.2016.07.004","volume":"20","author":"Barrows N.J.","year":"2016","unstructured":"Barrows N.J.; Campos R.K.; Powell S.T.; Prasanth K.R.; Schott-Lerner G.; Soto-Acosta R.; Galarza-Mu\u00f1oz G.; McGrath E.L.; Urrabaz-Garza R.; Gao J.; Wu P.; Menon R.; Saade G.; Fernandez-Salas I.; Rossi S.L.; Vasilakis N.; Routh A.; Bradrick S.S.; Garcia-Blanco M.A.; A Screen of FDA-approved drugs for inhibitors of zika virus infection. Cell Host Microbe 2016,20(2),259-270","journal-title":"Cell Host Microbe"},{"key":"ref=85","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.antiviral.2018.10.006","volume":"160","author":"Phoo W.W.","year":"2018","unstructured":"Phoo W.W.; Zhang Z.; Wirawan M.; Chew E.J.C.; Chew A.B.L.; Kouretova J.; Steinmetzer T.; Luo D.; Structures of Zika virus NS2B-NS3 protease in complex with peptidomimetic inhibitors. Antiviral Res 2018,160,17-24","journal-title":"Antiviral Res"},{"key":"ref=86","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.antiviral.2018.05.005","volume":"155","author":"Chaudhuri S.","year":"2018","unstructured":"Chaudhuri S.; Symons J.A.; Deval J.; Innovation and trends in the development and approval of antiviral medicines: 1987-2017 and beyond. Antiviral Res 2018,155,76-88","journal-title":"Antiviral Res"},{"key":"ref=87","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.antiviral.2017.02.009","volume":"141","author":"Chen L.","year":"2017","unstructured":"Chen L.; Liu Y.; Wang S.; Sun J.; Wang P.; Xin Q.; Zhang L.; Xiao G.; Wang W.; Antiviral activity of peptide inhibitors derived from the protein E stem against Japanese encephalitis and Zika viruses. Antiviral Res 2017,141,140-149","journal-title":"Antiviral Res"},{"key":"ref=88","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.micinf.2010.09.005","volume":"13","author":"Kaufmann B.","year":"2011","unstructured":"Kaufmann B.; Rossmann M.G.; Molecular mechanisms involved in the early steps of flavivirus cell entry. Microbes Infect 2011,13(1),1-9","journal-title":"Microbes Infect"},{"key":"ref=89","doi-asserted-by":"publisher","first-page":"338","DOI":"10.3390\/v9110338","volume":"9","author":"Zhang X.","year":"2017","unstructured":"Zhang X.; Jia R.; Shen H.; Wang M.; Yin Z.; Cheng A.; Structures and functions of the envelope glycoprotein in flavivirus infections. Viruses 2017,9(11),338","journal-title":"Viruses"},{"key":"ref=90","doi-asserted-by":"publisher","first-page":"15672","DOI":"10.1038\/ncomms15672","volume":"8","author":"Yu Y.","year":"2017","unstructured":"Yu Y.; Deng Y.Q.; Zou P.; Wang Q.; Dai Y.; Yu F.; Du L.; Zhang N.N.; Tian M.; Hao J.N.; Meng Y.; Li Y.; Zhou X.; Fuk-Woo Chan J.; Yuen K.Y.; Qin C.F.; Jiang S.; Lu L.; A peptide-based viral inactivator inhibits Zika virus infection in pregnant mice and fetuses. Nat Commun 2017,8,15672","journal-title":"Nat Commun"},{"key":"ref=91","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.virol.2005.02.002","volume":"334","author":"Lorin C.","year":"2005","unstructured":"Lorin C.; Saidi H.; Belaid A.; Zairi A.; Baleux F.; Hocini H.; B\u00e9lec L.; Hani K.; Tangy F.; The antimicrobial peptide dermaseptin S4 inhibits HIV-1 infectivity in vitro. Virology 2005,334(2),264-275","journal-title":"Virology"},{"key":"ref=92","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0025333","volume":"6","author":"Barlow P.G.","year":"2011","unstructured":"Barlow P.G.; Svoboda P.; Mackellar A.; Nash A.A.; York I.A.; Pohl J.; Davidson D.J.; Donis R.O.; Antiviral activity and increased host defense against influenza infection elicited by the human cathelicidin LL-37. PLoS One 2011,6(10)","journal-title":"PLoS One"},{"key":"ref=93","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0073659","volume":"8","author":"Currie S.M.","year":"2013","unstructured":"Currie S.M.; Findlay E.G.; McHugh B.J.; Mackellar A.; Man T.; Macmillan D.; Wang H.; Fitch P.M.; Schwarze J.; Davidson D.J.; The human cathelicidin LL-37 has antiviral activity against respiratory syncytial virus. PLoS One 2013,8(8)","journal-title":"PLoS One"},{"key":"ref=94","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.4049\/jimmunol.172.3.1763","volume":"172","author":"Howell M.D.","year":"2004","unstructured":"Howell M.D.; Jones J.F.; Kisich K.O.; Streib J.E.; Gallo R.L.; Leung D.Y.M.; Selective killing of vaccinia virus by LL-37: implications for eczema vaccinatum. J Immunol 2004,172(3),1763-1767","journal-title":"J Immunol"},{"key":"ref=95","doi-asserted-by":"publisher","first-page":"722","DOI":"10.3389\/fimmu.2018.00722","volume":"9","author":"He M.","year":"2018","unstructured":"He M.; Zhang H.; Li Y.; Wang G.; Tang B.; Zhao J.; Huang Y.; Zheng J.; Cathelicidin-derived antimicrobial peptides inhibit zika virus through direct inactivation and Interferon pathway. Front Immunol 2018,9,722","journal-title":"Front Immunol"},{"key":"ref=96","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1038\/415389a","volume":"415","author":"Zasloff M.","year":"2002","unstructured":"Zasloff M.; Antimicrobial peptides of multicellular organisms. Nature 2002,415(6870),389-395","journal-title":"Nature"},{"key":"ref=97","year":"2016","unstructured":"NEWS, N.B.C. Infected Mosquitoes Can't Transmit Zika Virus, Study Finds, Available at:2016","journal-title":"Infected Mosquitoes Can't Transmit Zika Virus, Study Finds,"},{"key":"ref=98","author":"Park Y.H.","year":"2014","unstructured":"Park Y.H.; Lim J.H.; Seo B.J.; Rice-fermented food composition containing a rice-sweetened liquid, fermented by means of kimchi lactobacillus, as an effective ingredient, and having antibacterial and antiviraleffects U.S. Patent: 201403563382014","journal-title":"Rice-fermented food composition containing a rice-sweetened liquid, fermented by means of kimchi lactobacillus, as an effective ingredient, and having antibacterial and antiviraleffects"},{"key":"ref=99","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/376219","volume":"2013","author":"Liderot K.","year":"2013","unstructured":"Liderot K.; Ahl M.; Ozenci V.; Secondary bacterial infections in patients with seasonal influenza A and pandemic H1N1. BioMed Res Int 2013,2013","journal-title":"BioMed Res Int"},{"key":"ref=100","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1080\/07388551.2017.1368445","volume":"38","author":"Bajpai V.K.","year":"2018","unstructured":"Bajpai V.K.; Chandra V.; Kim N.H.; Rai R.; Kumar P.; Kim K.; Aeron A.; Kang S.C.; Maheshwari D.K.; Na M.; Rather I.A.; Park Y.H.; Ghost probiotics with a combined regimen: a novel therapeutic approach against the Zika virus, an emerging world threat. Crit Rev Biotechnol 2018,38(3),438-454","journal-title":"Crit Rev Biotechnol"},{"key":"ref=101","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.1126\/science.aai9309","volume":"354","author":"Zhang Z.","year":"2016","unstructured":"Zhang Z.; Li Y.; Loh Y.R.; Phoo W.W.; Hung A.W.; Kang C.; Luo D.; Crystal structure of unlinked NS2B-NS3 protease from Zika virus. Science 2016,354(6319),1597-1600","journal-title":"Science"},{"key":"ref=102","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1038\/nsmb1073","volume":"13","author":"Erbel P.","year":"2006","unstructured":"Erbel P.; Schiering N.; D\u2019Arcy A.; Renatus M.; Kroemer M.; Lim S.P.; Yin Z.; Keller T.H.; Vasudevan S.G.; Hommel U.; Structural basis for the activation of flaviviral NS3 proteases from dengue and West Nile virus. Nat Struct Mol Biol 2006,13(4),372-373","journal-title":"Nat Struct Mol Biol"},{"key":"ref=103","doi-asserted-by":"publisher","first-page":"3459","DOI":"10.1002\/1873-3468.12443","volume":"590","author":"Gruba N.","year":"2016","unstructured":"Gruba N.; Rodriguez Martinez J.I.; Grzywa R.; Wysocka M.; Skore\u0144ski M.; Burmistrz M.; \u0141\u0119cka M.; Lesner A.; Sie\u0144czyk M.; Pyr\u0107 K.; Substrate profiling of Zika virus NS2B-NS3 protease. FEBS Lett 2016,590(20),3459-3468","journal-title":"FEBS Lett"},{"key":"ref=104","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1021\/acs.jmedchem.6b01021","volume":"60","author":"Nitsche C.","year":"2017","unstructured":"Nitsche C.; Zhang L.; Weigel L.F.; Schilz J.; Graf D.; Bartenschlager R.; Hilgenfeld R.; Klein C.D.; Peptide-boronic acid inhibitors of flaviviral proteases: medicinal chemistry and structural biology. J Med Chem 2017,60(1),511-516","journal-title":"J Med Chem"},{"key":"ref=105","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1126\/science.aag2419","volume":"353","author":"Lei J.","year":"2016","unstructured":"Lei J.; Hansen G.; Nitsche C.; Klein C.D.; Zhang L.; Hilgenfeld R.; Crystal structure of Zika virus NS2B-NS3 protease in complex with a boronate inhibitor. Science 2016,353(6298),503-505","journal-title":"Science"},{"key":"ref=106","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1016\/j.str.2017.06.006","volume":"25","author":"Li Y.","year":"2017","unstructured":"Li Y.; Zhang Z.; Phoo W.W.; Loh Y.R.; Wang W.; Liu S.; Chen M.W.; Hung A.W.; Keller T.H.; Luo D.; Kang C.; Structural dynamics of zika virus NS2B-NS3 protease binding to dipeptide inhibitors. Structure 2017,25(8),1242-1250.e3","journal-title":"Structure"},{"key":"ref=107","doi-asserted-by":"publisher","first-page":"e00045","DOI":"10.1128\/JVI.00045-17","volume":"91","author":"Lin K-H.","year":"2017","unstructured":"Lin K-H.; Ali A.; Rusere L.; Soumana D.I.; Kurt Yilmaz N.; Schiffer C.A.; Dengue virus NS2B\/NS3 protease inhibitors exploiting the prime side. J Virol 2017,91(10),e00045-e17","journal-title":"J Virol"},{"key":"ref=108","doi-asserted-by":"publisher","first-page":"14762","DOI":"10.1038\/ncomms14762","volume":"8","author":"Zhao B.","year":"2017","unstructured":"Zhao B.; Yi G.; Du F.; Chuang Y.C.; Vaughan R.C.; Sankaran B.; Kao C.C.; Li P.; Structure and function of the Zika virus full-length NS5 protein. Nat Commun 2017,8,14762","journal-title":"Nat Commun"},{"key":"ref=109","doi-asserted-by":"publisher","first-page":"e01970","DOI":"10.1128\/JVI.01970-16","volume":"91","author":"Best S.M.","year":"2017","unstructured":"Best S.M.; The Many Faces of the Flavivirus NS5 protein in antagonism of type I interferon signaling. J Virol 2017,91(3),e01970-e16","journal-title":"J Virol"},{"key":"ref=110","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1016\/j.bbrc.2017.10.016","volume":"493","author":"Wang C.","year":"2017","unstructured":"Wang C.; Yang S.N.Y.; Smith K.; Forwood J.K.; Jans D.A.; Nuclear import inhibitor N-(4-hydroxyphenyl) retinamide targets Zika virus (ZIKV) nonstructural protein 5 to inhibit ZIKV infection. Biochem Biophys Res Commun 2017,493(4),1555-1559","journal-title":"Biochem Biophys Res Commun"},{"key":"ref=111","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1007\/978-981-10-8727-1_15","volume":"1062","author":"Jans D.A.","year":"2018","unstructured":"Jans D.A.; Martin A.J.; Nucleocytoplasmic trafficking of dengue non-structural protein 5 as a target for antivirals. Adv Exp Med Biol 2018,1062,199-213","journal-title":"Adv Exp Med Biol"},{"key":"ref=112","doi-asserted-by":"publisher","first-page":"e00554","DOI":"10.1128\/JVI.00554-17","volume":"91","author":"Xin Q-L.","year":"2017","unstructured":"Xin Q-L.; Deng C-L.; Chen X.; Wang J.; Wang S-B.; Wang W.; Deng F.; Zhang B.; Xiao G.; Zhang L-K.; Quantitative proteomic analysis of mosquito C6\/36 cells reveals host proteins involved in zika virus infection. J Virol 2017,91(12),e00554-e17","journal-title":"J Virol"},{"key":"ref=113","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.chembiol.2012.01.003","volume":"19","author":"Kisselev A.F.","year":"2012","unstructured":"Kisselev A.F.; van der Linden W.A.; Overkleeft H.S.; Proteasome inhibitors: an expanding army attacking a unique target. Chem Biol 2012,19(1),99-115","journal-title":"Chem Biol"},{"key":"ref=114","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/S0960-894X(98)00029-8","volume":"8","author":"Adams J.","year":"1998","unstructured":"Adams J.; Behnke M.; Chen S.; Cruickshank A.A.; Dick L.R.; Grenier L.; Klunder J.M.; Ma Y.T.; Plamondon L.; Stein R.L.; Potent and selective inhibitors of the proteasome: dipeptidyl boronic acids. Bioorg Med Chem Lett 1998,8(4),333-338","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=115","year":"2017","unstructured":"UPI Skin mucus of South Indian frog kills flu virus, Available at:2017","journal-title":"Skin mucus of South Indian frog kills flu virus,"},{"key":"ref=116","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.bcp.2018.04.008","volume":"154","author":"Gopala Reddy S.B.","year":"2018","unstructured":"Gopala Reddy S.B.; Chin W.X.; Shivananju N.S.; Dengue virus NS2 and NS4: Minor proteins, mammoth roles. Biochem Pharmacol 2018,154,54-63","journal-title":"Biochem Pharmacol"},{"key":"ref=117","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1007\/978-981-10-8727-1_9","volume":"1062","author":"Lescar J.","year":"2018","unstructured":"Lescar J.; Soh S.; Lee L.T.; Vasudevan S.G.; Kang C.; Lim S.P.; The dengue virus replication complex: From RNA replication to protein-protein interactions to evasion of innate immunity. Adv Exp Med Biol 2018,1062,115-129","journal-title":"Adv Exp Med Biol"},{"key":"ref=118","doi-asserted-by":"publisher","DOI":"10.1038\/emi.2016.48","author":"Zhu Z.","year":"2016","unstructured":"Zhu Z.; Chan J.F-W.; Tee K-M.; Choi G.K-Y.; Lau S.K-P.; Woo P.C-Y.; Tse H.; Yuen K-Y.; Comparative genomic analysis of pre-epidemic and epidemic zika virus strains for virological factors potentially associated with the rapidly expanding epidemic. Emerg Microbes Infect, 2016","journal-title":"Emerg Microbes Infect,"},{"key":"ref=119","doi-asserted-by":"publisher","first-page":"2180","DOI":"10.3389\/fimmu.2018.02180","volume":"9","author":"Laureti M.","year":"2018","unstructured":"Laureti M.; Narayanan D.; Rodriguez-Andres J.; Fazakerley J.K.; Kedzierski L.; Flavivirus receptors: diversity, identity, and cell entry. Front Immunol 2018,9,2180","journal-title":"Front Immunol"},{"key":"ref=120","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.compbiolchem.2017.10.011","volume":"71","author":"Kazmirchuk T.","year":"2017","unstructured":"Kazmirchuk T.; Dick K.; Burnside D.J.; Barnes B.; Moteshareie H.; Hajikarimlou M.; Omidi K.; Ahmed D.; Low A.; Lettl C.; Hooshyar M.; Schoenrock A.; Pitre S.; Babu M.; Cassol E.; Samanfar B.; Wong A.; Dehne F.; Green J.R.; Golshani A.; Designing anti-Zika virus peptides derived from predicted human-Zika virus protein-protein interactions. Comput Biol Chem 2017,71,180-187","journal-title":"Comput Biol Chem"},{"key":"ref=121","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1038\/nm.4322","volume":"23","author":"Shan C.","year":"2017","unstructured":"Shan C.; Muruato A.E.; Nunes B.T.D.; Luo H.; Xie X.; Medeiros D.B.A.; Wakamiya M.; Tesh R.B.; Barrett A.D.; Wang T.; Weaver S.C.; Vasconcelos P.F.C.; Rossi S.L.; Shi P.Y.; A live-attenuated Zika virus vaccine candidate induces sterilizing immunity in mouse models. Nat Med 2017,23(6),763-767","journal-title":"Nat Med"},{"key":"ref=122","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1038\/ni0504-460","volume":"5","author":"Levine M.M.","year":"2004","unstructured":"Levine M.M.; Sztein M.B.; Vaccine development strategies for improving immunization: the role of modern immunology. Nat Immunol 2004,5(5),460-464","journal-title":"Nat Immunol"},{"key":"ref=123","doi-asserted-by":"publisher","first-page":"5706","DOI":"10.1016\/j.vaccine.2013.09.046","volume":"31","author":"Englund J.A.","year":"2013","unstructured":"Englund J.A.; Karron R.A.; Cunningham C.K.; Larussa P.; Melvin A.; Yogev R.; Handelsman E.; Siberry G.K.; Thumar B.; Schappell E.; Bull C.V.; Chu H.Y.; Schaap-Nutt A.; Buchholz U.; Collins P.L.; Schmidt A.C.; International Maternal Pediatric Adolescent AIDS Clinical Trials (IMPAACT) P1096 Study Group. Safety and infectivity of two doses of live-attenuated recombinant cold-passaged human parainfluenza type 3 virus vaccine rHPIV3cp45 in HPIV3-seronegative young children. Vaccine 2013,31(48),5706-5712","journal-title":"Vaccine"},{"key":"ref=124","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0168-1656(99)00107-8","volume":"73","author":"Liljeqvist S.","year":"1999","unstructured":"Liljeqvist S.; St\u00e5hl S.; Production of recombinant subunit vaccines: protein immunogens, live delivery systems and nucleic acid vaccines. J Biotechnol 1999,73(1),1-33","journal-title":"J Biotechnol"},{"key":"ref=125","doi-asserted-by":"publisher","DOI":"10.5772\/33496","author":"Moisa A.A.","year":"2012","unstructured":"Moisa A.A.; Kolesanova E.F.; Synthetic Peptide Vaccines: Insight and Control of Infectious Disease in Global Scenario Available at:2012","journal-title":"Insight and Control of Infectious Disease in Global Scenario"},{"key":"ref=126","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.ejim.2017.08.001","volume":"44","author":"Wahid B.","year":"2017","unstructured":"Wahid B.; Ali A.; Rafique S.; Idrees M.; Current status of therapeutic and vaccine approaches against Zika virus. Eur J Intern Med 2017,44,12-18","journal-title":"Eur J Intern Med"},{"key":"ref=127","doi-asserted-by":"publisher","first-page":"282","DOI":"10.2174\/156720111795256192","volume":"8","author":"Skwarczynski M.","year":"2011","unstructured":"Skwarczynski M.; Toth I.; Peptide-based subunit nanovaccines. Curr Drug Deliv 2011,8(3),282-289","journal-title":"Curr Drug Deliv"},{"key":"ref=128","doi-asserted-by":"publisher","first-page":"837","DOI":"10.2217\/pgs.09.25","volume":"10","author":"Poland G.A.","year":"2009","unstructured":"Poland G.A.; Ovsyannikova I.G.; Jacobson R.M.; Application of pharmacogenomics to vaccines. Pharmacogenomics 2009,10(5),837-852","journal-title":"Pharmacogenomics"},{"key":"ref=129","doi-asserted-by":"publisher","first-page":"2688","DOI":"10.1016\/S0264-410X(00)00554-5","volume":"19","author":"Rappuoli R.","year":"2001","unstructured":"Rappuoli R.; Reverse vaccinology, a genome-based approach to vaccine development. Vaccine 2001,19(17-19),2688-2691","journal-title":"Vaccine"},{"key":"ref=130","doi-asserted-by":"publisher","first-page":"2963","DOI":"10.1016\/j.vaccine.2007.01.065","volume":"25","author":"Barocchi M.A.","year":"2007","unstructured":"Barocchi M.A.; Censini S.; Rappuoli R.; Vaccines in the era of genomics: the pneumococcal challenge. Vaccine 2007,25(16),2963-2973","journal-title":"Vaccine"},{"key":"ref=131","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1016\/j.apjtm.2016.07.004","volume":"9","author":"Dar H.","year":"2016","unstructured":"Dar H.; Zaheer T.; Rehman M.T.; Ali A.; Javed A.; Khan G.A.; Babar M.M.; Waheed Y.; Prediction of promiscuous T-cell epitopes in the Zika virus polyprotein: An in silico approach. Asian Pac J Trop Med 2016,9(9),844-850","journal-title":"Asian Pac J Trop Med"},{"key":"ref=132","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.meegid.2016.08.037","volume":"45","author":"Dikhit M.R.","year":"2016","unstructured":"Dikhit M.R.; Ansari M.Y.; Vijaymahantesh ; Kalyani ; Mansuri R.; Sahoo B.R.; Dehury B.; Amit A.; Topno R.K.; Sahoo G.C.; Ali V.; Bimal S.; Das P.; Computational prediction and analysis of potential antigenic CTL epitopes in Zika virus: A first step towards vaccine development. Infect Genet Evol 2016,45,187-197","journal-title":"Infect Genet Evol"},{"key":"ref=133","doi-asserted-by":"publisher","first-page":"235","DOI":"10.4172\/2161-0703.1000235","volume":"5","author":"Weltman J.K.","year":"2016","unstructured":"Weltman J.K.; Computer-assisted vaccine design by analysis of zika virus E proteins obtained either from humans or from Aedes mosquitos. J Med Microb Diagn 2016,5,235","journal-title":"J Med Microb Diagn"},{"key":"ref=134","doi-asserted-by":"publisher","first-page":"226","DOI":"10.3390\/microorganisms7080226","volume":"7","author":"Prasasty V.D.","year":"2019","unstructured":"Prasasty V.D.; Grazzolie K.; Rosmalena R.; Yazid F.; Ivan F.X.; Sinaga E.; Peptide-based subunit vaccine design of T- and B-cells multi-epitopes against zika virus using immunoinformatics approaches. Microorganisms 2019,7(8),226","journal-title":"Microorganisms"},{"key":"ref=135","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1089\/vim.2016.0033","volume":"29","author":"Ashfaq U.A.","year":"2016","unstructured":"Ashfaq U.A.; Ahmed B.; De Novo structural modeling and conserved epitopes prediction of zika virus envelop protein for vaccine development. Viral Immunol 2016,29(7),436-443","journal-title":"Viral Immunol"},{"key":"ref=136","first-page":"2","volume":"1","author":"Gupta P.","year":"2014","unstructured":"Gupta P.; Computer aided drug design and discovery-an economical approach to drug discovery industry. Austin J Biotechnol Bioeng 2014,1(4),2","journal-title":"Austin J Biotechnol Bioeng"},{"key":"ref=137","first-page":"46","volume":"4","author":"Badawi M.M.","year":"2016","unstructured":"Badawi M.M.; Osman M.M.; Alla A.A.F.; Ahmedani A.M.; Abdalla M.H.; Gasemelseed M.M.; Elsayed A.A.; Salih M.A.; Highly conserved epitopes of zika envelope glycoprotein may act as a novel peptide vaccine with high coverage: immunoinformatics approach. Am J Biomed Res 2016,4,46-60","journal-title":"Am J Biomed Res"},{"key":"ref=138","doi-asserted-by":"publisher","first-page":"44","DOI":"10.30750\/ijpbr.2.4.10","volume":"2","author":"Shawan M.M.A.K.","year":"2014","unstructured":"Shawan M.M.A.K.; Mahmud H.A.; Hasan M.; Parvin A.; Rahman N.; Rahman S.M.B.; In silico modelling and immunoinformatics probing disclose the epitope based peptide vaccine against zika virus envelope glycoprotein. Ind J Pharm Biol Res 2014,2(4),44-45","journal-title":"Ind J Pharm Biol Res"},{"key":"ref=139","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1111\/imm.12656","volume":"149","author":"Alam A.","year":"2016","unstructured":"Alam A.; Ali S.; Ahamad S.; Malik M.Z.; Ishrat R.; From ZikV genome to vaccine: in silico approach for the epitope-based peptide vaccine against Zika virus envelope glycoprotein. Immunology 2016,149(4),386-399","journal-title":"Immunology"},{"key":"ref=140","doi-asserted-by":"publisher","first-page":"37313","DOI":"10.1038\/srep37313","volume":"6","author":"Mirza M.U.","year":"2016","unstructured":"Mirza M.U.; Rafique S.; Ali A.; Munir M.; Ikram N.; Manan A.; Salo-Ahen O.M.; Idrees M.; Towards peptide vaccines against Zika virus: Immunoinformatics combined with molecular dynamics simulations to predict antigenic epitopes of Zika viral proteins. Sci Rep 2016,6,37313","journal-title":"Sci Rep"},{"key":"ref=141","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1111\/j.1751-7915.2011.00276.x","volume":"5","author":"De Gregorio E.","year":"2012","unstructured":"De Gregorio E.; Rappuoli R.; Vaccines for the future: learning from human immunology. Microb Biotechnol 2012,5(2),149-155","journal-title":"Microb Biotechnol"},{"key":"ref=142","doi-asserted-by":"publisher","DOI":"10.1098\/rsob.120139","volume":"3","author":"Patronov A.","year":"2013","unstructured":"Patronov A.; Doytchinova I.; T-cell epitope vaccine design by immunoinformatics. Open Biol 2013,3(1)","journal-title":"Open Biol"},{"key":"ref=143","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1002\/rmv.602","volume":"19","author":"Yang X.","year":"2009","unstructured":"Yang X.; Yu X.; An introduction to epitope prediction methods and software. Rev Med Virol 2009,19(2),77-96","journal-title":"Rev Med Virol"},{"key":"ref=144","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1007\/s13365-017-0513-4","volume":"23","author":"Singh M.V.","year":"2017","unstructured":"Singh M.V.; Weber E.A.; Singh V.B.; Stirpe N.E.; Maggirwar S.B.; Preventive and therapeutic challenges in combating Zika virus infection: are we getting any closer? J Neurovirol 2017,23(3),347-357","journal-title":"J Neurovirol"},{"key":"ref=145","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1016\/j.devcel.2015.01.019","volume":"32","author":"Yamaguchi Y.","year":"2015","unstructured":"Yamaguchi Y.; Miura M.; Programmed cell death in neurodevelopment. Dev Cell 2015,32(4),478-490","journal-title":"Dev Cell"}],"container-title":["Current Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/eurekaselect.com\/article\/download\/168892","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,12]],"date-time":"2023-09-12T22:03:06Z","timestamp":1694556186000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/168892\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,1]]},"references-count":145,"journal-issue":{"issue":"23","published-print":{"date-parts":[[2020,7,1]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0929867326666190111115132","relation":{},"ISSN":["0929-8673"],"issn-type":[{"value":"0929-8673","type":"print"}],"subject":[],"published":{"date-parts":[[2020,7,1]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2018-10-07","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-11-22","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-12-28","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-07-01","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}